Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Investing Activities: 2018-2025

Historic Cash from Investing Activities for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to -$2.2 million.

  • Organogenesis Holdings' Cash from Investing Activities rose 13.00% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.9 million, marking a year-over-year decrease of 28.66%. This contributed to the annual value of -$10.0 million for FY2024, which is 58.82% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Cash from Investing Activities stood at -$2.2 million, which was up 38.57% from -$3.6 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Cash from Investing Activities peaked at -$1.9 million during Q2 2024, and registered a low of -$16.7 million during Q3 2021.
  • For the 3-year period, Organogenesis Holdings' Cash from Investing Activities averaged around -$4.0 million, with its median value being -$3.4 million (2024).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 131.09% in 2021, then skyrocketed by 74.93% in 2024.
  • Organogenesis Holdings' Cash from Investing Activities (Quarterly) stood at -$5.2 million in 2021, then crashed by 103.86% to -$10.7 million in 2022, then surged by 68.81% to -$3.3 million in 2023, then fell by 1.11% to -$3.4 million in 2024, then increased by 13.00% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q3 2025, -$3.6 million for Q2 2025, and -$3.6 million during Q1 2025.